A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis
Recurrence of BV following standard treatment is unacceptably high. Posttreatment recurrence is distressing for women, and it imposes a considerable burden on the health care system.
Guardado en:
Autores principales: | Erica L. Plummer, Lenka A. Vodstrcil, Michelle Doyle, Jennifer A. Danielewski, Gerald L. Murray, Glenda Fehler, Christopher K. Fairley, Dieter M. Bulach, Suzanne M. Garland, Eric P. F. Chow, Jane S. Hocking, Catriona S. Bradshaw |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d550f43c8e5d4ccbba8ce0a380d8c24a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
por: Catriona S Bradshaw, et al.
Publicado: (2012) -
The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review
por: Larissa K. Ratten, et al.
Publicado: (2021) -
Penile Microbiota and Female Partner Bacterial Vaginosis in Rakai, Uganda
por: Cindy M. Liu, et al.
Publicado: (2015) -
Modelling the multiple anatomical site transmission of Mycoplasma genitalium among men who have sex with men in Australia
por: Xianglong Xu, et al.
Publicado: (2021) -
Modern understanding of bacterial vaginosis
por: Aleksey A. Khryanin, et al.
Publicado: (2021)